Home > PE Ratio > KOPRAN

KOPRAN
PE (Price/Earnings) Ratio

The Current P/E Ratio of KOPRAN is 31.06.

Share Price ₹260.2Apr 15,2024
Market Cap ₹1,254.2 Cr
Earnings-TTM₹40.4 CrTTM-Consolidated Results
Price/Earnings31.06xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results
KOPRAN is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KOPRAN

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KOPRAN is calculated as :

Current Market Cap [ ₹1,254.2 Cr] as on Apr 15,2024

(/) Earnings [ ₹40.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 31.06x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KOPRAN , the investors are currently willing to pay 31.06 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KOPRAN !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KOPRAN over the last five years.

Historical PE (Price/Earnings) ratio chart of KOPRAN


PE Ratio Performance Analysis for KOPRAN

- KOPRAN 's latest p/e ratio is 31.06x.

- KOPRAN 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 12.37x.

- KOPRAN 's operated at median p/e ratio of 7.49x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 22.24x.

- KOPRAN 's p/e ratio hit its five-year low in Mar2020 of 5.22x.


How does KOPRAN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KOPRAN 40.3731.061,254.2
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6341.09369,774.0
CIPLA LTD3,744.0329.79111,518.0
DR REDDYS LABORATORIES LTD5,209.4019.25100,258.0
ZYDUS LIFESCIENCES LTD2,954.2031.8594,082.9
DIVIS LABORATORIES LTD1,382.9771.3298,636.2
MANKIND PHARMA LTD1,743.3052.0490,721.3
TORRENT PHARMACEUTICALS LTD1,494.0057.0785,267.9
LUPIN LTD1,809.7440.5073,291.0
AUROBINDO PHARMA LTD2,777.8922.9063,624.1
ABBOTT INDIA LTD1,145.5848.5855,650.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KOPRAN 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.25x
Max industry PE 71.32x
Median industry PE 40.50x
Average industry PE 40.50x



You may also like the below Video Courses